DK0814790T3 - Indgivelse af ketamin med henblik på afgiftning - Google Patents

Indgivelse af ketamin med henblik på afgiftning

Info

Publication number
DK0814790T3
DK0814790T3 DK96906452T DK96906452T DK0814790T3 DK 0814790 T3 DK0814790 T3 DK 0814790T3 DK 96906452 T DK96906452 T DK 96906452T DK 96906452 T DK96906452 T DK 96906452T DK 0814790 T3 DK0814790 T3 DK 0814790T3
Authority
DK
Denmark
Prior art keywords
ketamine
administration
present
substance addiction
treatment
Prior art date
Application number
DK96906452T
Other languages
Danish (da)
English (en)
Inventor
Stuart L Weg
Original Assignee
Stuart L Weg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1995/002418 external-priority patent/WO1995022965A2/en
Priority claimed from US08/477,365 external-priority patent/US5679714A/en
Application filed by Stuart L Weg filed Critical Stuart L Weg
Application granted granted Critical
Publication of DK0814790T3 publication Critical patent/DK0814790T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
DK96906452T 1995-02-24 1996-02-14 Indgivelse af ketamin med henblik på afgiftning DK0814790T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US1995/002418 WO1995022965A2 (en) 1994-02-25 1995-02-24 Nasal and ocular administration of ketamine to manage pain and for detoxification
US08/477,365 US5679714A (en) 1995-06-07 1995-06-07 Administration of ketamine for detoxification and treatment of tobacco addiction
PCT/US1996/002047 WO1996025925A1 (en) 1995-02-24 1996-02-14 Nasal and ocular administration of ketamine to manage pain and for detoxification

Publications (1)

Publication Number Publication Date
DK0814790T3 true DK0814790T3 (da) 2003-11-10

Family

ID=26789531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96906452T DK0814790T3 (da) 1995-02-24 1996-02-14 Indgivelse af ketamin med henblik på afgiftning

Country Status (9)

Country Link
EP (1) EP0814790B1 (de)
JP (1) JP4173538B2 (de)
AT (1) ATE245024T1 (de)
AU (1) AU733284B2 (de)
CA (1) CA2213567C (de)
DE (1) DE69629108T2 (de)
DK (1) DK0814790T3 (de)
ES (1) ES2205018T3 (de)
WO (1) WO1996025925A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015022972B1 (pt) 2013-03-15 2023-02-14 Janssen Pharmaceutica Nv Composição farmacêutica de cloridrato de s-cetamina e formas de dosagem da mesma
MA40620A (fr) 2014-09-15 2016-03-24 Janssen Pharmaceutica Nv Régimes posologiques spécifiques au génotype val66met (snp rs6265) et méthodes pour le traitement de la dépression
US10179136B2 (en) 2015-06-19 2019-01-15 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10555952B2 (en) 2015-06-19 2020-02-11 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10166240B2 (en) 2015-06-19 2019-01-01 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10391102B2 (en) 2015-06-19 2019-08-27 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
CA2989319C (en) * 2015-06-19 2019-02-05 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for anesthesiological applications
CN112423789A (zh) 2017-12-22 2021-02-26 詹森药业有限公司 用于治疗抑郁症的艾司氯胺酮
EP3505157B1 (de) * 2017-12-29 2021-12-08 Celon Pharma S.A. Trockenpulver-ketamin zusammensetzung zur pulmonalen verabreichung bei behandlungsresistenter depression
BR112021017457A2 (pt) 2019-03-05 2021-11-16 Janssen Pharmaceuticals Inc Escetamina para o tratamento de depressão
CN116942648A (zh) * 2022-04-26 2023-10-27 宜昌人福药业有限责任公司 艾司氯胺酮液体制剂及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5543434A (en) * 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain

Also Published As

Publication number Publication date
DE69629108D1 (de) 2003-08-21
CA2213567C (en) 2010-01-26
JP4173538B2 (ja) 2008-10-29
EP0814790B1 (de) 2003-07-16
ATE245024T1 (de) 2003-08-15
EP0814790A1 (de) 1998-01-07
JPH11500729A (ja) 1999-01-19
AU4982796A (en) 1996-09-11
CA2213567A1 (en) 1996-08-29
AU733284B2 (en) 2001-05-10
DE69629108T2 (de) 2004-04-22
WO1996025925A1 (en) 1996-08-29
ES2205018T3 (es) 2004-05-01

Similar Documents

Publication Publication Date Title
MX9603633A (es) Administracion nasal y ocular de ketamina para manejar el dolor y para la detoxificacion.
DK0814790T3 (da) Indgivelse af ketamin med henblik på afgiftning
ATE276676T1 (de) Zusammensetzung zur reduzierung oder entwöhnung von nikotinabhängigkeit
NO20060913L (no) Behandling av avhengighetsabstinens
CA1152003A (en) Means and method for aiding individuals to stop smoking
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
HUP0300048A2 (hu) Transzdermális vagy transzmukozális dohányzásról leszoktató készítmények, melyek nikotintartalmú hatóanyagkombinációt tartalmaznak és alkalmazásuk
DK0863760T3 (da) Anvendelse af forbindelser med antimineralcorticoid virkning over for narkotikafvænning
RO116771B1 (ro) Metodă pentru prevenirea sau tratamentul dependenţei, toleranţei sau abuzului de benzodiazepine
EA004184B1 (ru) Способ уменьшения или прекращения курения
UA27884C2 (uk) Засіб для лікування розладів, викликаних зловживанням ліками та спосіб лікування або профілактики зазначеним засобом абстинентного синдрому
ATE301462T1 (de) Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden
MX9706456A (es) Administracion nasal y ocular de la cetamina para manejar el dolor y para la destoxificacion.
BR9908190A (pt) Processos para tratar a dor especìfica de fêmea em um paciente fêmea, e para tratar a dor crÈnica em um paciente
NO943293L (no) Anvendelse av et medikament ved avvenning mot röyk
Richmond et al. Controlled Trial of the 24-Hour Transdermal Nicotine Patch in Conjunction With Cognitive-Behavioural Therapy: 6-Months’ Results
SU1537259A1 (ru) Средство, подавл ющее влечение к никотину и табачному дыму
Hendrie Alternative strategies and new treatments for smoking
Antonuccio Will the nicotine patch really stick?
KR20030022348A (ko) 흡연을 줄이거나 금연하기 위한 방법
PROTOCOL Western Regional Emergency Medical Advisory Committee
Radzius et al. Cigarette Smoking not Affected by Cocaine Self-Administration
UA42352A (uk) Спосіб лікування хронічного гастродуоденіту із супутніми захворюваннями внутрішніх органів